Skip to content

Author

Yu-Yong Jiang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

QHHP Ameliorates MASH Through Modulation of a Cyp4a32-PPARγ-CD36-Associated Lipotoxic Axis.

Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive stage of metabolic dysfunction-associated fatty liver disease, for which effective pharmacological therapies remain limited. Qinggan Huatan Huoxue Prescription (QHHP) has been used clinically in the management of fatty liver disease and related me...

Fei-Xiang Xiong, Feng-Na Yan, Yu-Yong Jiang et al. · 0 citations
Review Open access Aug 2026

Precision treatment and frontier advances of glycyrrhizin preparations in drug-induced liver injury (DILI)

This article systematically expounds the precise treatment strategies of glycyrrhizin preparations based on DILI classification, severity, and special populations, and elaborately analyzes their cutting-edge mechanisms of action such as regulation of the gut-liver axis and epigenetic modifications.

Di Qiu, Zi-Xuan Gao, Lu Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.